Quanterix (QTRX) late Monday reported a Q4 net loss of $0.30 per diluted share, wider than a $0.23 loss a year earlier.
One analyst polled by FactSet expected a $0.26 loss.
Revenue for the quarter ended Dec. 31 was $35.2 million, compared with $31.5 million a year earlier.
Analysts expected $34.5 million.
For 2025, the medical device company is expecting between $140.0 million to $146.0 million in revenue.
Analysts are looking for $155.1 million.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。